spacer
home > epc > Spring 2010
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2010

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

   
Text
PDF
bullet
Marketplace & Business
With the world's biggest population and one of its fastest growing pharmaceutical markets, the benefits of conducting clinical trials in China are overwhelming. Albert Liou at PAREXEL International explores the Chinese R&D landscape in more detail.
 
view
download pdf
Gail Kniveton at i3 Pharma Resourcing examines the critical but often overlooked area of staff training, arguing that in times of economic difficulty, it is more important than ever for companies to choose the right training strategy and exploit it to the full.  
view
download pdf
Management teams seeking improvements to their bottom line and operational performance are showing renewed interest in Lean and Six Sigma ways of thinking. Julian Mosquera at LCP Consulting takes a fresh look at the most effective means of adopting these methodologies.  
view
download pdf
bullet
Legal & Regulatory
Christopher Beckham and Bruce C Haas at Fitzpatrick, Cella, Harper & Scinto discuss why intellectual property procurement and enforcement have become greater priorities for the pharma industry in the context of the global economic downturn.  
view
download pdf
bullet
Clinical Development
Paper-based methods of collecting patient data are increasingly being cast aside in favour of electronic solutions. Mark Taggart and patrick Hughes at Exco InTouch look at how the mobile phone revolution can help to increase efficiency and reliability in the patient reporting process  
view
download pdf
Adrian Iancu at Global Clinical Trials reviews the impressive development of the clinical research landscape in Romania since its accession to the EU in 2007, looking at the country's advantages in terms of demographics and research experience.  
view
download pdf
Negotiating financial agreements between sponsors and CROs can be fraught with difficulty. Anna Ravdel at Synergy Research Grouo examines the change order process in detail, outlining the key choices to consider.  
view
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS
Lee Ann Applegate at the University Hospital of Lausanne (CHUV) and Dominique P Pioletti at the Swiss Federal Institute of Technology Lausanne (EPFL) advocate an interdisciplinary approach to developing new therapies, which can help to assure patient safety.  
view
download pdf
Although the practice of medicine has traditionally focused on population analyses, it is now widely acknowledged that techniques of personalised medicine can offer significant benefits to patients; David S Lester of ITHW reviews developments in the field.  
view
download pdf
Kathryn Chapman and Vicky Robinson at the National Centre for Replacement, Refinement and Reduction of Animals in Research present the need to change accepted testing methods in light of the growing redundancy of animal research in certain areas.  
view
download pdf
bullet
Data Management & IT Solutions
A bottle of wine has more in common with standards for clinical data than you might think, explain Dave Iberson-Hurst and AJ de Montjoie at CDISC, with insight into the past, present and future of CDISC standards.  
view
download pdf
Andrew MacGarvey at Quanticate discusses the shift away from 'treating sickness' and towards 'managing wellness' in the healthcare industry, and considers the role that the collection, cleaning and reporting of clinical data has to play in this progression.  
view
download pdf
bullet
LABS & Logistics
Amy Furlong at ERT returns to the theme of centralised ECG data collection, looking at the advantage of this paradigm when compared to the traditional decentralisd model, which include greater consistency and cost savings.  
view
download pdf
Everyone involved in the cold chain is aware of the need to keep things cool, but a recent report in the UK has highlighted the dangers of temperatures falling too low; Ana Carmona-Rodriguez at Gemini Data Loggers (UK) Ltd and Dawn Brown, freelance Consultant, show how data logging can help meet regulatory requirements.  
view
download pdf
Jean Bédard from Alternatives Technologie Pharma Inc discusses how automatic monitoring technology can make the business of avoiding temperature extremes in the pharmaceutical cool chain simpler and more transparent.  
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

CPhI Worldwide Pharma Awards finalists unveiled

CPhI Worldwide, organised by UBM, announces the finalists of the 2017 CPhI Pharma Awards. Such was the quality; a record 98 entries have been shortlisted, with the winners due to be announced during this year’s CPhI Worldwide in Frankfurt.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

Industry Events

BIO-Europe® 2017

6-8 November 2017, Messedamm 26 14055 Berlin Germany

The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement